From SARS to the Omicron variant of COVID-19: China's policy adjustments and changes to prevent and control infectious diseases

被引:17
|
作者
Luo, Mingyu [1 ]
Liu, Qinmei [1 ]
Wang, Jinna [1 ]
Gong, Zhenyu [1 ]
机构
[1] Zhejiang Prov Ctr Dis Control & Prevent, Dept Communicable Dis Control & Prevent, Hangzhou 310051, Zhejiang, Peoples R China
关键词
COVID-19; infectious disease; physical containment strategies; vaccination; global health; public health;
D O I
10.5582/bst.2021.01535
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
The COVID-19 pandemic has been the biggest public health crisis in a century. Since it was initially reported in 2019, the duration and intensity of its impacts are still in serious question around the world, and it is about to enter its third year. The first public health revolution failed to achieve its ultimate targets, as previously contained infectious diseases seem to have returned, and new infectious diseases continue to emerge. The prevention and control of infectious diseases is still a public health priority worldwide. After SARS, China adjusted a series of its infectious disease policies. In order to ensure the effectiveness and implementation of prevention and control interventions, the government should integrate the concept of public health. Perhaps we need a global public health system at the government level to fight the potential threat of infectious disease. This system could include multifaceted strategies, not just specific prevention and control interventions, and it could also be a comprehensive system to ensure unimpeded communication and cooperation as well as sustainable development.
引用
收藏
页码:418 / 423
页数:6
相关论文
共 50 条
  • [31] Analysis of 394 COVID-19 cases infected with Omicron variant in Shenzhen: impact of underlying diseases to patient’s symptoms
    Peiyan Zhang
    Zhao Cai
    Zhiguang He
    Peifen Chen
    Weibo Wu
    Yuanlong Lin
    Shiyan Feng
    Ling Peng
    Jianming Li
    Jing Yuan
    Liang Yang
    Fuxiang Wang
    Yingxia Liu
    Hongzhou Lu
    European Journal of Medical Research, 27
  • [32] Governmental Inter-sectoral Strategies to Prevent and Control COVID-19 in a Megacity: A Policy Brief From Shanghai, China
    He, Xiaolin
    Jiang, Ping
    Wu, Qiong
    Lai, Xiaobin
    Liang, Yan
    FRONTIERS IN PUBLIC HEALTH, 2022, 10
  • [33] Clinical Characteristics of Mild Patients with Breakthrough Infection of Omicron Variant in China after Relaxing the Dynamic Zero COVID-19 Policy
    He, Yingyu
    Zhang, Fang
    Liu, Yan
    Xiong, Zhou
    Zheng, Shangen
    Liu, Wanbing
    Liu, Lei
    VACCINES, 2023, 11 (05)
  • [34] Can the SARS-CoV-2 Omicron Variant Confer Natural Immunity against COVID-19?
    Abas, Abdul Hawil
    Marfuah, Siti
    Idroes, Rinaldi
    Kusumawaty, Diah
    Fatimawali
    Park, Moon Nyeo
    Siyadatpanah, Abolghasem
    Alhumaydhi, Fahad A.
    Mahmud, Shafi
    Tallei, Trina Ekawati
    Bin Emran, Talha
    Kim, Bonglee
    MOLECULES, 2022, 27 (07):
  • [35] Evaluation of Bebtelovimab for Treatment of Covid-19 During the SARS-CoV-2 Omicron Variant Era
    McCreary, Erin K.
    Kip, Kevin E.
    Collins, Kevin
    Minnier, Tami E.
    Snyder, Graham M.
    Steiner, Ashley
    Meyers, Russell
    Borneman, Tina
    Adam, Michelle
    Thurau, Lauren
    Yealy, Donald M.
    Huang, David T.
    Bariola, J. Ryan
    Schmidhofer, Mark
    Wadas, Richard J.
    Angus, Derek C.
    Kip, Paula L.
    Marroquin, Oscar C.
    OPEN FORUM INFECTIOUS DISEASES, 2022, 9 (10):
  • [36] Omicron variant of SARS-CoV-2: Genomics, transmissibility, and responses to current COVID-19 vaccines
    Araf, Yusha
    Akter, Fariya
    Tang, Yan-dong
    Fatemi, Rabeya
    Parvez, Md Sorwer Alam
    Zheng, Chunfu
    Hossain, Md Golzar
    JOURNAL OF MEDICAL VIROLOGY, 2022, 94 (05) : 1825 - 1832
  • [37] Booster COVID-19 vaccination against the SARS-CoV-2 Omicron variant: a systematic review
    Du, Yuxuan
    Chen, Long
    Shi, Yuan
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2022, 18 (05)
  • [38] FROM SARS TO COVID-19: BALANCE OF CHINA'S CRIMINAL LAW SYSTEM
    Sun Yirong
    TSINGHUA CHINA LAW REVIEW, 2020, 12 (02): : 399 - 411
  • [39] Infectious diseases and football - lessons not only from COVID-19
    Munoz, Monica Duarte Y.
    Meyer, Tim
    SCIENCE AND MEDICINE IN FOOTBALL, 2020, 4 (02) : 85 - 86
  • [40] An overview of the reclassification of COVID-19 of the Infectious Diseases Control Law in Japan
    Kitahara, Kanako
    Nishikawa, Yoshihiro
    Yokoyama, Hirokazu
    Kikuchi, Yoshinobu
    Sakoi, Masami
    GLOBAL HEALTH & MEDICINE, 2023, 5 (02): : 70 - 74